<?xml version="1.0" encoding="UTF-8"?>
<p id="p0030">The study of phloroglucinol derivatives have been a hot research topic of the Eucalyptus natural products for many years due to their numerous pharmacological activities (
 <xref rid="bib56" ref-type="bibr">Shang et al., 2016</xref>). They possess a wide range of anti-inflammatory, anticancer, antimicrobial, antiallergic, enzyme inhibitory, angiotensinase inhibitory and neuroregenerative activities (
 <xref rid="bib63" ref-type="bibr">Singh et al., 2009</xref>; 
 <xref rid="bib75" ref-type="bibr">Yang et al., 2007</xref>; 
 <xref rid="bib23" ref-type="bibr">Hussein and El-Anssary, 2018</xref>). It has also been shown that phloroglucinol derivatives can be used to modulate the central nervous system, for example, in the treatment of depression, to elevate mood, to increase behavioral initiative, and the like (
 <xref rid="bib49" ref-type="bibr">Roemer and Grothe, 2012</xref>). Therefore, lipophilic secondary compounds of Eucalyptus plants have multiple biological and pharmacological activities, but their mechanism of action and the relationship between structure and activity are under study.
</p>
